Your child is neurodivergent. Should you tell everyone?

Pavel Tabutov’s family had been invited to a gathering near his Los Angeles exurb home to hear a friend’s daughter perform with her singing group. But it wasn’t a great night to go out. His three young kids were cranky, and it would be a crowded social event where the kids would need to sit…

Read More

Mixed Bag Phase 3 Data for ADHD Treatment Presented at ASHP Meeting

CONFERENCE REPORTER: Researchers shared mixed good news for the novel treatment centanafadine for treating attention-deficit/hyperactivity disorder at the American Society of Health-System Pharmacists 2023 Summer Meetings and Exhibition.1 Specifically, they found centanafadine had a better safety profile and demonstrated more favorable tolerability but was less effective than lisdexamfetamine dimesylate (Vyvanse) for adults with ADHD.

Read More

Investigating the Long-Term Safety of ADHD Medication for Children and Adolescents

[Excerpt] Now, a recent study from the Attention Deficit Hyperactivity Drugs Use Chronic Effects (ADDUCE) project, published in The Lancet, aimed to address these concerns by investigating the safety of methylphenidate in children and adolescents over a 2-year period. Technology Networks spoke with Dr. Sarah Inglis, trial manager for the ADDUCE study, to learn more about its findings…

Read More

ADHD in Children: Focus on the Positives

Jami Demuth is the mother of three children in their teens, all of whom have attention deficit hyperactivity disorder (ADHD). Her parenting strategy? She encourages them to find ways to use their ADHD symptoms to their advantage.

Read More